These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11145432)

  • 1. Dissection of the signalling requirements of interleukin-6-stimulated myeloma cell growth.
    French JD; Tschumper RC; Jelinek DF
    Acta Oncol; 2000; 39(7):777-81. PubMed ID: 11145432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of IL-6-mediated growth control of myeloma cells using a gp130 chimeric receptor approach.
    French JD; Tschumper RC; Jelinek DF
    Leukemia; 2002 Jun; 16(6):1189-96. PubMed ID: 12040452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-10 and Gp130 cytokines in human multiple myeloma.
    Klein B; Lu ZY; Gu ZJ; Costes V; Jourdan M; Rossi JF
    Leuk Lymphoma; 1999 Jun; 34(1-2):63-70. PubMed ID: 10350333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
    Westendorf JJ; Jelinek DF
    J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130.
    Zhang XG; Gu JJ; Lu ZY; Yasukawa K; Yancopoulos GD; Turner K; Shoyab M; Taga T; Kishimoto T; Bataille R
    J Exp Med; 1994 Apr; 179(4):1337-42. PubMed ID: 8145045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-21 is a growth and survival factor for human myeloma cells.
    Brenne AT; Ro TB; Waage A; Sundan A; Borset M; Hjorth-Hansen H
    Blood; 2002 May; 99(10):3756-62. PubMed ID: 11986233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update of gp130 cytokines in multiple myeloma.
    Klein B
    Curr Opin Hematol; 1998 May; 5(3):186-91. PubMed ID: 9664158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential interleukin-6 (IL-6) responses of three established myeloma cell lines in the presence of soluble human IL-6 receptors.
    Diamant M; Hansen MB; Rieneck K; Svenson M; Yasukawa K; Bendtzen K
    Leuk Res; 1996 Apr; 20(4):291-301. PubMed ID: 8642840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and production of interleukin 10 in human myeloma cell lines.
    Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
    Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6, CD45 and the src-kinases in myeloma cell proliferation.
    Ishikawa H; Tsuyama N; Abroun S; Liu S; Li FJ; Otsuyama K; Zheng X; Kawano MM
    Leuk Lymphoma; 2003 Sep; 44(9):1477-81. PubMed ID: 14565647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells.
    Wen XY; Stewart AK; Sooknanan RR; Henderson G; Hawley TS; Reimold AM; Glimcher LH; Baumann H; Malek LT; Hawley RG
    Int J Oncol; 1999 Jul; 15(1):173-8. PubMed ID: 10375612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.
    Nishimoto N; Ogata A; Shima Y; Tani Y; Ogawa H; Nakagawa M; Sugiyama H; Yoshizaki K; Kishimoto T
    J Exp Med; 1994 Apr; 179(4):1343-7. PubMed ID: 8145046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.
    Howlett M; Judd LM; Jenkins B; La Gruta NL; Grail D; Ernst M; Giraud AS
    Gastroenterology; 2005 Sep; 129(3):1005-18. PubMed ID: 16143138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of protein phosphatase 1 and 2A in an IL-6-mediated autocrine growth loop of human myeloma cells.
    Kang HS; Lee BS; Yang Y; Park CW; Ha HJ; Pyun KH; Choi I
    Cell Immunol; 1996 Mar; 168(2):174-83. PubMed ID: 8640863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
    Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
    Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
    Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
    Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gp130 in human myeloma/plasmacytoma.
    Tani Y; Nishimoto N; Ogata A; Shima Y; Yoshizaki K; Kishimoto T
    Curr Top Microbiol Immunol; 1995; 194():229-33. PubMed ID: 7895494
    [No Abstract]   [Full Text] [Related]  

  • 19. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line.
    Minami M; Inoue M; Wei S; Takeda K; Matsumoto M; Kishimoto T; Akira S
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3963-6. PubMed ID: 8632998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of residues in the putative 5th helical region of human interleukin-6, important for activation of the IL-6 signal transducer, gp130.
    Brakenhoff JP; Bos HK; Grötzinger J; Rose-John S; Aarden LA
    FEBS Lett; 1996 Oct; 395(2-3):235-40. PubMed ID: 8898103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.